Chartwell Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$58.3M |
| 2 |
Radian Group
RDN
|
+$50.8M |
| 3 |
Pultegroup
PHM
|
+$42M |
| 4 |
CAVM
Cavium, Inc.
CAVM
|
+$39.7M |
| 5 |
Adobe
ADBE
|
+$34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ManpowerGroup
MAN
|
+$76.7M |
| 2 |
SS&C Technologies
SSNC
|
+$71.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$57.6M |
| 4 |
JCP
J.C. Penney Company, Inc.
JCP
|
+$56.8M |
| 5 |
Salesforce
CRM
|
+$53.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.82% |
| 2 | Financials | 17.22% |
| 3 | Consumer Discretionary | 15.09% |
| 4 | Healthcare | 11.48% |
| 5 | Industrials | 11.34% |
Similar funds
Chartwell Investment Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Chartwell Investment Partners held 464 positions worth $5.61B, up 0.03% from $5.61B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Chartwell Investment Partners withdrew a net $351M in Q3 2016, closing 45 positions and reducing 183 holdings. Its most notable exit was ManpowerGroup, an estimated $76.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Chartwell Investment Partners opened a new position in BioMarin Pharmaceuticals worth $57.3M.
- Chartwell Investment Partners's largest Q3 2016 buy was BioMarin Pharmaceuticals: 619,625 shares worth $57.3M.
- Chartwell Investment Partners added most to Pultegroup in Q3 2016, an estimated $42M increase.
- Chartwell Investment Partners's biggest Q3 2016 reduction was SS&C Technologies, cutting an estimated $71.2M.
- Chartwell Investment Partners fully exited ManpowerGroup in Q3 2016, selling an estimated $76.7M.
- Chartwell Investment Partners's ten largest holdings make up 16% of its $5.61B portfolio in Q3 2016.
- Chartwell Investment Partners opened 65 new positions and closed 45 in Q3 2016.
- Chartwell Investment Partners's portfolio value rose 0.03% quarter-over-quarter to $5.61B.
Based on Chartwell Investment Partners's 13F filing for Q3 2016, filed 15 Nov 2016.